Cargando…

Experimental Pharmacotherapy for Dry Eye Disease: A Review

Dry eye disease (DED) is a complex multifactorial disease showing heterogenous symptoms, including dryness, photophobia, ocular discomfort, irritation and burning but also pain. These symptoms can affect visual function leading to restrictions in daily life activities and reduction in work productiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baiula, Monica, Spampinato, Santi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001578/ https://www.ncbi.nlm.nih.gov/pubmed/33790661 http://dx.doi.org/10.2147/JEP.S237487

Ejemplares similares

Quantitative Systems Pharmacology and Biased Agonism at Opioid Receptors: A Potential Avenue for Improved Analgesics
por: Bedini, Andrea, et al.
Publicado: (2022)

Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy
por: Baiula, Monica, et al.
Publicado: (2014)

Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration
por: Baiula, Monica, et al.
Publicado: (2021)

Novel Ligands Targeting α(4)β(1) Integrin: Therapeutic Applications and Perspectives
por: Baiula, Monica, et al.
Publicado: (2019)

Therapeutic Targeting of Eosinophil Adhesion and Accumulation in Allergic Conjunctivitis
por: Baiula, Monica, et al.
Publicado: (2012)

Design and Pharmacological Characterization of α(4)β(1) Integrin Cyclopeptide Agonists: Computational Investigation of Ligand Determinants for Agonism versus Antagonism
por: Anselmi, Michele, et al.
Publicado: (2023)

Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases
por: Rusciano, Dario, et al.
Publicado: (2023)

Design of α/β-Hybrid Peptide Ligands of α4β1 Integrin Equipped with a Linkable Side Chain for Chemoselective Biofunctionalization of Microstructured Materials
por: Anselmi, Michele, et al.
Publicado: (2021)

Modeling the Pharmacotherapy Cost and Outcomes of Primary Open-Angle Glaucoma With Dry Eye
por: Tachkov, Konstantin, et al.
Publicado: (2019)

Side chain effect in the modulation of α(v)β(3)/α(5)β(1) integrin activity via clickable isoxazoline-RGD-mimetics: development of molecular delivery systems
por: Ferrazzano, Lucia, et al.
Publicado: (2020)

Selective Integrin Ligands Promote Cell Internalization of the Antineoplastic Agent Fluorouracil
por: Baiula, Monica, et al.
Publicado: (2021)

Integrin-mediated adhesive properties of neutrophils are reduced by hyperbaric oxygen therapy in patients with chronic non-healing wound
por: Baiula, Monica, et al.
Publicado: (2020)

Design, Pharmacological Characterization, and Molecular Docking of Minimalist Peptidomimetic Antagonists of α(4)β(1) Integrin
por: Baiula, Monica, et al.
Publicado: (2023)

Tear Metabolomics in Dry Eye Disease: A Review
por: Yazdani, Mazyar, et al.
Publicado: (2019)

Cataract surgery and dry eye disease: A review
por: Naderi, Khayam, et al.
Publicado: (2020)

Experimental Pharmacotherapy for COVID-19: The Latest Advances
por: Pagliano, Pasquale, et al.
Publicado: (2021)

Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist
por: Baiula, Monica, et al.
Publicado: (2011)

Review of Pharmacotherapy for Tinnitus
por: Kim, Sang Hoon, et al.
Publicado: (2021)

Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist
por: Bedini, Andrea, et al.
Publicado: (2020)

Automation of dry eye disease quantitative assessment: A review
por: Brahim, Ikram, et al.
Publicado: (2022)

Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future
por: Navarini, Luca, et al.
Publicado: (2020)

Effect of IRT5 probiotics on dry eye in the experimental dry eye mouse model
por: Moon, Jayoon, et al.
Publicado: (2020)

Experimental Models, Induction Protocols, and Measured Parameters in Dry Eye Disease: Focusing on Practical Implications for Experimental Research
por: Rahman, Md. Mahbubur, et al.
Publicado: (2021)

Pharmacotherapy as an adjunct to vitrectomy
por: Villegas, Victor M., et al.
Publicado: (2021)

Autologous Serum Eye Drops for Dry Eye: Systematic Review
por: Quan, Nicolas G., et al.
Publicado: (2023)

Is Sjögren’s syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests
por: Garcia, Denny Marcos, et al.
Publicado: (2018)

Keratoprosthesis in dry eye disease
por: Sharma, Supriya, et al.
Publicado: (2023)

Bacteria and Dry Eye: A Narrative Review
por: Wang, Yuchen, et al.
Publicado: (2022)

Dry eye disease: A review of anti-inflammatory therapies
por: Nguyen, Annie, et al.
Publicado: (2023)

Tear film osmolarity and dry eye disease: a review of the literature
por: Potvin, Richard, et al.
Publicado: (2015)

A Narrative Review of Current Understanding and Classification of Dry Eye Disease with New Insights on the Impact of Dry Eye during the COVID-19 Pandemic
por: Barabino, Stefano
Publicado: (2021)

α-Linolenic Acid–Valproic Acid Conjugates: Toward Single-Molecule Polypharmacology for Multiple Sclerosis
por: Rossi, Michele, et al.
Publicado: (2020)

Review of Pharmacotherapy Trialed for Management of the Coronavirus Disease-19
por: Hall, Kimberly, et al.
Publicado: (2021)

A review on drug-induced dry eye disease
por: Kam, Ka Wai, et al.
Publicado: (2023)

Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia
por: Fabbrini, Andrea, et al.
Publicado: (2021)

Pharmacotherapy for Neuropathic Pain: A Review
por: Fornasari, Diego
Publicado: (2017)

Dry Eye: an Inflammatory Ocular Disease
por: Hessen, Michelle, et al.
Publicado: (2014)

Animal models of dry eye disease: Useful, varied and evolving (Review)
por: Huang, Wei, et al.
Publicado: (2021)

Hormones and dry eye disease
por: Gorimanipalli, Bhavya, et al.
Publicado: (2023)

Formulation Considerations for the Management of Dry Eye Disease
por: Agarwal, Priyanka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0lc71hhni915ml3ga8k27kpr78